|

Standard disease-directed therapy Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • Incyte Corporation2

Indications

  • Myeloproliferative Neoplasms2
  • Cancer2

Birmingham, Alabama2 trials

A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

The University of Alabama At Birmingham

Phase 1
Study of INCA036978 in Participants With Myeloproliferative Neoplasms

University of Alabama At Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.